Profit rose to Rs.59.8 crore in the fiscal first quarter, from Rs.46.6 crore in the year-ago period. When fully commissioned, SRC will have a total area of 200,000 sq ft that will support integrated discovery and development programmes. The profit was notched up on a 17.5% increase in revenue to Rs.274.5 crore from Rs.233.7 crore. The company also said it commissioned its viral testing facility in Bengaluru on 1 July. During the first quarter, the company commissioned the first phase of Syngene Research Centre (SRC), spread across 50,000 square feet (sqft) area in Bengaluru.

Source: Mint July 21, 2016 14:48 UTC